Hence, increasing P2RY1 functional studies will help to shed lights on promoting the development of pharmaceutical drugs against swallowing disorders related diseases such as dysphagia and aspiration pneumonia in the clinic. The gene discussed is P2RY1; the disease is Dysphagia.